Details of the Drug

General Information of Drug (ID: DMQZOA9)

Drug Name

CDCA1-derived epitope peptide vaccine

Synonyms

CDCA1-derived epitope peptide vaccine (HLA-A2402 restricted, prostate cancer); CDCA1-derived epitope peptide vaccine (prostate cancer), Iwate Medical University/Tokyo University/Oita University; Cell division cycle associated gene 1-derived epitope peptide vaccine (prostate cancer), Iwate Medical University/Tokyo University/Oita University; CDCA1-derived epitope peptide vaccine (HLA-A2402 restricted, prostate cancer), Iwate Medical University/Tokyo University/Oita University

Indication

Disease Entry	ICD 11	Status	REF
Prostate cancer	2C82.0	Phase 1/2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D0E2DL

References

1	ClinicalTrials.gov (NCT01225471) Novel Peptide Vaccination for Patients With Advanced Prostate Cancer. U.S. National Institutes of Health.